Filter Results:
(960)
Show Results For
- All HBS Web
(960)
- People (7)
- News (417)
- Research (425)
- Multimedia (8)
- Faculty Publications (117)
Show Results For
- All HBS Web
(960)
- People (7)
- News (417)
- Research (425)
- Multimedia (8)
- Faculty Publications (117)
- 03 Mar 2009
- First Look
First Look: March 3, 2009
and complementary effects across channels to provide sales forecasting, promotion planning, and customer relationship management guidance to multichannel managers. We investigate three contingencies in a... View Details
Keywords: Martha Lagace
- Article
The Business Case for Investing in Physician Well-Being
By: Tait D. Shanafelt, Joel Goh and Christine A. Sinsky
Importance: Widespread burnout among physicians has been recognized for more than two decades. Extensive evidence indicates that physician burnout has important personal and professional consequences.
Observations: A lack of awareness regarding... View Details
Observations: A lack of awareness regarding... View Details
Keywords: Physicians; Well-being; ROI; Health; Welfare or Wellbeing; Ethics; Investment Return; Health Industry
Shanafelt, Tait D., Joel Goh, and Christine A. Sinsky. "The Business Case for Investing in Physician Well-Being." JAMA Internal Medicine 177, no. 12 (December 2017): 1826–1832. (doi:10.1001/jamainternmed.2017.4340.)
- 17 Mar 2020
- News
Reflections on the Ongoing Coronavirus Crisis
- October 2022
- Supplement
The SAH Group: The Time is Right, Spreadsheet Supplement
By: Juan Alcacer and Alpana Thapar
In January 2021, Jalila Mezni, CEO of the SAH Group, was preparing to present the company’s future growth plans to its board of directors. The Tunisian company was a leading producer and distributor of personal care and packaged hygiene products. In 2019, it expanded... View Details
Keywords: Growth Strategy; Entrepreneurship; Investment Decisions; Growth Management; Vertical Integration; Distribution; Competition; Strategy; Supply Chain; Presentations; Market Entry and Exit; Product Positioning; Pulp and Paper Industry; Pulp and Paper Industry; Pulp and Paper Industry; Tunisia
- 08 Oct 2015
- Blog Post
Why We Recruit: DaVita Healthcare Partners, Inc.
commitment to clinical excellence and improving patients' health and quality of life. DaVita focuses on setting worldwide standards for clinical, social, View Details
Keywords: Health Care
- October 2022
- Supplement
The SAH Group: The Time is Right, Instructor Spreadsheet
By: Juan Alcacer and Alpana Thapar
In January 2021, Jalila Mezni, CEO of the SAH Group, was preparing to present the company’s future growth plans to its board of directors. The Tunisian company was a leading producer and distributor of personal care and packaged hygiene products. In 2019, it expanded... View Details
Keywords: Growth Strategy; Entrepreneurship; Investment Decisions; Growth Management; Vertical Integration; Distribution; Competition; Strategy; Supply Chain; Presentations; Product Positioning; Market Entry and Exit; Pulp and Paper Industry; Pulp and Paper Industry; Pulp and Paper Industry; Tunisia
- June 2021
- Article
From Predictions to Prescriptions: A Data-driven Response to COVID-19
By: Dimitris Bertsimas, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg and Cynthia Zeng
The COVID-19 pandemic has created unprecedented challenges worldwide. Strained healthcare providers make difficult decisions on patient triage, treatment and care management on a daily basis. Policy makers have imposed social distancing measures to slow the disease, at... View Details
Keywords: COVID-19; Health Pandemics; AI and Machine Learning; Forecasting and Prediction; Analytics and Data Science
Bertsimas, Dimitris, Léonard Boussioux, Ryan Cory-Wright, Arthur Delarue, Vassilis Digalakis Jr, Alexander Jacquillat, Driss Lahlou Kitane, Galit Lukin, Michael Lingzhi Li, Luca Mingardi, Omid Nohadani, Agni Orfanoudaki, Theodore Papalexopoulos, Ivan Paskov, Jean Pauphilet, Omar Skali Lami, Bartolomeo Stellato, Hamza Tazi Bouardi, Kimberly Villalobos Carballo, Holly Wiberg, and Cynthia Zeng. "From Predictions to Prescriptions: A Data-driven Response to COVID-19." Health Care Management Science 24, no. 2 (June 2021): 253–272.
- 20 Dec 2022
- Blog Post
Thinking About an MBA? Think About Your Purpose
Microsoft (whose purpose is “to empower every person and every organization on the planet to achieve more”), and Warby Parker (which seeks “to inspire View Details
- 29 May 2001
- Research & Ideas
How Technological Disruption Changes Everything
the fundamental causal mechanisms through which our lives have improved," Christensen said. Health Care Takes A Hit At the conference, Christensen looked forward to areas where disruptive technologies... View Details
- Forthcoming
- Book
How to Be Bold: The Surprising Science of Everyday Courage
By: Ranjay Gulati
What leads people to speak truth to power, share bold new ideas, or put their lives on the line? Most of us chalk it up to personality, presuming that our heroes are naturally fearless. But what if courage isn’t simply a matter of personality? What if it’s something... View Details
Gulati, Ranjay. How to Be Bold: The Surprising Science of Everyday Courage. HarperCollins, forthcoming.
- 10 Apr 2018
- First Look
First Look at New Research, April 10, 2018
https://www.hbs.edu/faculty/Pages/item.aspx?num=54331 forthcoming American Economic Journal: Economic Policy Physician Beliefs and Patient Preferences: A New Look at Regional Variation in Health View Details
Keywords: Sean Silverthorne
- 04 Dec 2017
- News
Why CVS Wants to Buy Aetna
- May 2024 (Revised February 2025)
- Case
Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell
By: Jon M. Jachimowicz and Alexis Lefort
Brooke Boyarsky Pratt (HBS ’13) enjoyed considerable success in her early career, quickly climbing the ranks to associate partner at McKinsey, and later becoming an executive vice president at Berkadia, a Berkshire Hathaway portfolio company. Throughout these years,... View Details
Keywords: Passion; Career; Career Planning; Purpose; Personal Development and Career; Mission and Purpose; Identity; Business Startups; Health Care and Treatment; Health Disorders; Growth and Development Strategy; Market Entry and Exit; Health Industry; United States
Jachimowicz, Jon M., and Alexis Lefort. "Choosing the Course of Passion: Brooke Boyarsky Pratt at knownwell." Harvard Business School Case 424-040, May 2024. (Revised February 2025.)
- 04 Oct 2018
- News
Precision medicine needs a business mindset in order to flourish
- November 2017
- Article
A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies
By: S. Balsari, P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough and T. Khanna
Cardiovascular disease is the leading cause of mortality from noncommunicable diseases (NCD) in India. The government’s National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke seeks to increase capacity building, screening,... View Details
Balsari, S., P. Vemulapalli, M. Gofine, K. Oswal, R. Merchant, S. Saunik, G. Greenough, and T. Khanna. "A Retrospective Analysis of Hypertension Screening at a Mass Gathering in India: Implications for Non-communicable Disease Control Strategies." Journal of Human Hypertension 31, no. 11 (November 2017): 750–753.
Raffaella Sadun
Raffaella Sadun is Charles E. Wilson Professor of Business Administration at Harvard Business School, and is a Co-Chair of Harvard Business School’s Project on Managing the Future of Work and co-PI of the Digital Reskilling Lab. Sadun received her PhD in Economics... View Details
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- May 2021
- Supplement
Paul Levy: Confronting a 'Corporate Campaign' (B)
By: James K. Sebenius and Isaac Silberberg
Paul Levy, CEO of the Beth Israel Deaconess Medical Center hospital is faced with a formidable negotiation campaign to unionize staff at BIDMC. Armed only with his personal blog, does Paul stand a chance against the union's multi-million dollar organizing budget? View Details
- 21 Aug 2015
- Blog Post
My Fear of Student Debt: Funding the HBS/HKS Joint Degree
How do you decide whether taking on student debt outweighs the professional and personal benefits of graduate school? This decision was hard for me. I spent four years after my undergraduate studies working... View Details